Table 3 Clustering of 38 DEGs according to the expression profiles of 16 patients with serous ovarian cancer; Up-regulation corresponds to log2 ratio > threshold while down-regulation to log2 ratio < minus value of threshold.
Threshold | Group 1 | Group 2 | Group 3 | Group 4 | ||||
|---|---|---|---|---|---|---|---|---|
| Â | up-regulated | down-regulated | up-regulated | down-regulated | up-regulated | down-regulated | up-regulated | down-regulated |
0.5 | 88.9% | 6.9% | 68.8% | 15.6% | 63.9% | 22.2% | 19.4% | 68.8% |
1.0 | 86.8% | 5.6% | 58.8% | 12.5% | 55.6% | 18.1% | 9.3% | 60.3% |
1.5 | 84.0% | 4.2% | 45.6% | 7.5% | 48.6% | 13.2% | 6.3% | 46.3% |
2.0 | 77.1% | 3.5% | 31.9% | 6.9% | 41.0% | 11.8% | 3.1% | 33.1% |
Accession no. (gene symbol) | NM_003143.1 (SSBP1) | AY871274 (RPL11) | NM_001867 (COX7C) BC013003 (ANP32B) | AK302766 (RBM5) NM_032682 (FOXP1) | ||||
| Â | NM_022873.2 (IFI6) | BC000523 (RPS24) | BC013003 (ANP32B) | NM_032682 (FOXP1) | ||||
| Â | NM_001355.3 (DDT) | BC012823 | NM_000978 (RPL23) | NG_001229 (NUDCP2) | ||||
| Â | NM_005532(IFI27) | NM_001101654(CXXC1) | NM_013974.1 (DDAH2) | AK025219 | ||||
| Â | NM_207429.2 (C11orf92) | NM_001034996(RPL14) | XM_002345433 | BC001120 (LGALS3) NM_032508.1 (TMEM185A) | ||||
| Â | NM_020529(NFKBIA) | NM_001037637(BTF3) | BC107854 (ATP6V1F) | Â | ||||
| Â | NM_032470(TNXB) | NM_001020(RPS16) | NM_001004333.3 (RNASEK) | NM_002292.3 (LAMB2) | ||||
| Â | EF177379 (NEAT1) | NR_003225(LGALS3) | NM_080390(TCEAL2) | AK293439 (XRCC6) | ||||
| Â | BC02359 (TFG) | NM_013318(BAT2L1) AK026649 | NM_001100167(MRVI1) | NM_001131005(MEF2C) NM_201442 (C1S) | ||||